Research and Markets has announced the addition of the "Global Dry Eye Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The results of the Dry Eye patients study are announced in this new report Global Dry Eye Epidemiology and Patient Flow Analysis Report 2017'.
The report provides insights into Dry Eye epidemiology, Dry Eye diagnosed patients, and Dry Eye treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Dry Eye derived from epidemiological analysis, percentage of patients diagnosed with Overactive Bladder, and percentage of patients treated with a therapy.
The study helps executives estimate Dry Eye market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Dry Eye prevalence, Dry Eye diagnosis rate, and Dry Eye treatment rate for the period 2016 - 2025.
Key Features of the Report:
- Dry Eye Patient Flow
- Dry Eye Prevalence
- Dry Eye Diagnosed Patients
- Dry Eye Treated Patients
Key Topics Covered:
1. Overactive Bladder: Disease Definition
2. Global Dry Eye Patient Flow
3. Dry Eye Patient Flow in the US
4. Dry Eye Patient Flow in Europe
5. Dry Eye Patient Flow in Germany
6. Dry Eye Patient Flow in France
7. Dry Eye Patient Flow in Spain
8. Dry Eye Patient Flow in Italy
9. Dry Eye Patient Flow in UK
10. Dry Eye Patient Flow in Japan
For more information about this report visit http://www.researchandmarkets.com/research/d8bchk/global_dry_eye.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170119006057/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Optical,
Optical
Disorders Drugs